CINCINNATI--(BUSINESS WIRE)--Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the latest five kits in the high performance ISOLATE II nucleic acid purification range – ISOLATE II miRNA, Plant miRNA, Biofluids RNA, RNA/DNA/Protein, and FFPE RNA/DNA Kits.
Based on the latest developments in silica membrane spin column technology and optimized buffer chemistry, with simple bind-wash-elute steps; the new Bioline ISOLATE II Purification Kits are designed for rapid, phenol-free isolation of highest quality nucleic acids, including miRNA, even from samples that are difficult to process. By using ISOLATE II Kits, researchers can expect superior yields, higher purity and integrity when compared to the previous generation of purification kits, as well as safe and convenient handling without the use of toxic chemicals.
Help employers find you! Check out all the jobs and post your resume.
Based on the latest developments in silica membrane spin column technology and optimized buffer chemistry, with simple bind-wash-elute steps; the new Bioline ISOLATE II Purification Kits are designed for rapid, phenol-free isolation of highest quality nucleic acids, including miRNA, even from samples that are difficult to process. By using ISOLATE II Kits, researchers can expect superior yields, higher purity and integrity when compared to the previous generation of purification kits, as well as safe and convenient handling without the use of toxic chemicals.
Help employers find you! Check out all the jobs and post your resume.
